Canada · Delayed Price · Currency is CAD KP Tissue Statistics
Total Valuation
KP Tissue has a market cap or net worth of CAD 122.90 million.
| Market Cap | 122.90M |
| Enterprise Value | n/a |
Important Dates
The next estimated earnings date is Tuesday, November 17, 2026.
| Earnings Date | Nov 17, 2026 |
| Ex-Dividend Date | Dec 31, 2026 |
Share Statistics
KP Tissue has 10.03 million shares outstanding. The number of shares has increased by 0.28% in one year.
| Current Share Class | 10.03M |
| Shares Outstanding | 10.03M |
| Shares Change (YoY) | +0.28% |
| Shares Change (QoQ) | +0.05% |
| Owned by Insiders (%) | 0.73% |
| Owned by Institutions (%) | 0.92% |
| Float | 9.96M |
Valuation Ratios
The trailing PE ratio is 11.86 and the forward PE ratio is 12.53.
| PE Ratio | 11.86 |
| Forward PE | 12.53 |
| PS Ratio | n/a |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.61 |
| P/FCF Ratio | 1.06 |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.00, with zero debt.
| Current Ratio | 1.00 |
| Quick Ratio | 1.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.21%.
| Return on Equity (ROE) | 14.21% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.33% |
| Revenue Per Employee | n/a |
| Profits Per Employee | 3,836 |
| Employee Count | 2,700 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.04% in the last 52 weeks. The beta is 0.38, so KP Tissue's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +30.04% |
| 50-Day Moving Average | 12.17 |
| 200-Day Moving Average | 11.96 |
| Relative Strength Index (RSI) | 56.91 |
| Average Volume (20 Days) | 16,778 |
Short Selling Information
The latest short interest is 273,691, so 2.74% of the outstanding shares have been sold short.
| Short Interest | 273,691 |
| Short Previous Month | 279,887 |
| Short % of Shares Out | 2.74% |
| Short % of Float | 2.75% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | 10.36M |
| Net Income | 10.36M |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | 1.03 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | n/a |
| Net Cash | n/a |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 76.29M |
| Book Value Per Share | 7.61 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | 116.29M |
| FCF Per Share | 11.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.84, which amounts to a dividend yield of 6.86%.
| Dividend Per Share | 0.84 |
| Dividend Yield | 6.86% |
| Dividend Growth (YoY) | 12.50% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 70.05% |
| FCF Payout Ratio | 6.99% |
| Buyback Yield | -0.28% |
| Shareholder Yield | 6.57% |
| Earnings Yield | 8.43% |
| FCF Yield | 94.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for KP Tissue is 13.13, which is 7.18% higher than the current price. The consensus rating is "Hold".
| Price Target | 13.13 |
| Price Target Difference | 7.18% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | -44.03% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |